Mignot, Grégoire <br/><br/>
The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  May 2008 
 - 6477-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.180.10.6477  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Benzamides<br/>Chemokine CCL2--metabolism<br/>Dendritic Cells--immunology<br/>Flow Cytometry<br/>Humans<br/>Imatinib Mesylate<br/>Interleukin-15--immunology<br/>Interleukin-2--administration & dosage<br/>Killer Cells, Natural--immunology<br/>Mice<br/>Mice, Mutant Strains<br/>Neoplasms, Experimental--drug therapy<br/>Piperazines--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Receptors, CCR2--metabolism<br/>Receptors, Interferon--immunology<br/>Interferon gamma Receptor